Report Overview
Glucagon is a metabolic hormone secreted by the pancreas that raises blood glucose levels by causing the liver to rapidly convert glycogen (the stored form of glucose) into glucose, which is then released into the bloodstream. Glucagon and insulin are two critical hormones in a glycemic control system that keeps blood glucose at the right level in healthy individual. Glucagon is a medicine which used to treat severe low blood sugar (hypoglycemia). Glucagon works by telling your body to release sugar (glucose) into the bloodstream to bring the blood sugar level back up.
The global Glucagon Drug market size was estimated at USD 575 million in 2023 and is projected to reach USD 979.73 million by 2032, exhibiting a CAGR of 6.10% during the forecast period.
North America Glucagon Drug market size was estimated at USD 165.91 million in 2023, at a CAGR of 5.23% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Glucagon Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Glucagon Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Glucagon Drug market in any manner.
Global Glucagon Drug Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novo Nordisk
Eli Lilly
Fresenius Kabi
Torrent Labs
Amphastar Pharmaceuticals
Xeris Pharmaceuticals
Market Segmentation (by Type)
Vials
Prefilled
Market Segmentation (by Application)
Hospital
Pharmacy
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Glucagon Drug Market
� Overview of the regional outlook of the Glucagon Drug Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Glucagon Drug Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Glucagon Drug, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Glucagon Drug
1.2 Key Market Segments
1.2.1 Glucagon Drug Segment by Type
1.2.2 Glucagon Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Glucagon Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Glucagon Drug Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Glucagon Drug Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Glucagon Drug Market Competitive Landscape
3.1 Global Glucagon Drug Sales by Manufacturers (2019-2025)
3.2 Global Glucagon Drug Revenue Market Share by Manufacturers (2019-2025)
3.3 Glucagon Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Glucagon Drug Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Glucagon Drug Sales Sites, Area Served, Product Type
3.6 Glucagon Drug Market Competitive Situation and Trends
3.6.1 Glucagon Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Glucagon Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Glucagon Drug Industry Chain Analysis
4.1 Glucagon Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Glucagon Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Glucagon Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Glucagon Drug Sales Market Share by Type (2019-2025)
6.3 Global Glucagon Drug Market Size Market Share by Type (2019-2025)
6.4 Global Glucagon Drug Price by Type (2019-2025)
7 Glucagon Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Glucagon Drug Market Sales by Application (2019-2025)
7.3 Global Glucagon Drug Market Size (M USD) by Application (2019-2025)
7.4 Global Glucagon Drug Sales Growth Rate by Application (2019-2025)
8 Glucagon Drug Market Consumption by Region
8.1 Global Glucagon Drug Sales by Region
8.1.1 Global Glucagon Drug Sales by Region
8.1.2 Global Glucagon Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Glucagon Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Glucagon Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Glucagon Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Glucagon Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Glucagon Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Glucagon Drug Market Production by Region
9.1 Global Production of Glucagon Drug by Region (2019-2025)
9.2 Global Glucagon Drug Revenue Market Share by Region (2019-2025)
9.3 Global Glucagon Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Glucagon Drug Production
9.4.1 North America Glucagon Drug Production Growth Rate (2019-2025)
9.4.2 North America Glucagon Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Glucagon Drug Production
9.5.1 Europe Glucagon Drug Production Growth Rate (2019-2025)
9.5.2 Europe Glucagon Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Glucagon Drug Production (2019-2025)
9.6.1 Japan Glucagon Drug Production Growth Rate (2019-2025)
9.6.2 Japan Glucagon Drug Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Glucagon Drug Production (2019-2025)
9.7.1 China Glucagon Drug Production Growth Rate (2019-2025)
9.7.2 China Glucagon Drug Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Novo Nordisk
10.1.1 Novo Nordisk Glucagon Drug Basic Information
10.1.2 Novo Nordisk Glucagon Drug Product Overview
10.1.3 Novo Nordisk Glucagon Drug Product Market Performance
10.1.4 Novo Nordisk Business Overview
10.1.5 Novo Nordisk Glucagon Drug SWOT Analysis
10.1.6 Novo Nordisk Recent Developments
10.2 Eli Lilly
10.2.1 Eli Lilly Glucagon Drug Basic Information
10.2.2 Eli Lilly Glucagon Drug Product Overview
10.2.3 Eli Lilly Glucagon Drug Product Market Performance
10.2.4 Eli Lilly Business Overview
10.2.5 Eli Lilly Glucagon Drug SWOT Analysis
10.2.6 Eli Lilly Recent Developments
10.3 Fresenius Kabi
10.3.1 Fresenius Kabi Glucagon Drug Basic Information
10.3.2 Fresenius Kabi Glucagon Drug Product Overview
10.3.3 Fresenius Kabi Glucagon Drug Product Market Performance
10.3.4 Fresenius Kabi Glucagon Drug SWOT Analysis
10.3.5 Fresenius Kabi Business Overview
10.3.6 Fresenius Kabi Recent Developments
10.4 Torrent Labs
10.4.1 Torrent Labs Glucagon Drug Basic Information
10.4.2 Torrent Labs Glucagon Drug Product Overview
10.4.3 Torrent Labs Glucagon Drug Product Market Performance
10.4.4 Torrent Labs Business Overview
10.4.5 Torrent Labs Recent Developments
10.5 Amphastar Pharmaceuticals
10.5.1 Amphastar Pharmaceuticals Glucagon Drug Basic Information
10.5.2 Amphastar Pharmaceuticals Glucagon Drug Product Overview
10.5.3 Amphastar Pharmaceuticals Glucagon Drug Product Market Performance
10.5.4 Amphastar Pharmaceuticals Business Overview
10.5.5 Amphastar Pharmaceuticals Recent Developments
10.6 Xeris Pharmaceuticals
10.6.1 Xeris Pharmaceuticals Glucagon Drug Basic Information
10.6.2 Xeris Pharmaceuticals Glucagon Drug Product Overview
10.6.3 Xeris Pharmaceuticals Glucagon Drug Product Market Performance
10.6.4 Xeris Pharmaceuticals Business Overview
10.6.5 Xeris Pharmaceuticals Recent Developments
11 Glucagon Drug Market Forecast by Region
11.1 Global Glucagon Drug Market Size Forecast
11.2 Global Glucagon Drug Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Glucagon Drug Market Size Forecast by Country
11.2.3 Asia Pacific Glucagon Drug Market Size Forecast by Region
11.2.4 South America Glucagon Drug Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Glucagon Drug by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Glucagon Drug Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Glucagon Drug by Type (2025-2032)
12.1.2 Global Glucagon Drug Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Glucagon Drug by Type (2025-2032)
12.2 Global Glucagon Drug Market Forecast by Application (2025-2032)
12.2.1 Global Glucagon Drug Sales (K MT) Forecast by Application
12.2.2 Global Glucagon Drug Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Glucagon Drug Market Size Comparison by Region (M USD)
Table 5. Global Glucagon Drug Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Glucagon Drug Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Glucagon Drug Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Glucagon Drug Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Glucagon Drug as of 2022)
Table 10. Global Market Glucagon Drug Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Glucagon Drug Sales Sites and Area Served
Table 12. Manufacturers Glucagon Drug Product Type
Table 13. Global Glucagon Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Glucagon Drug
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Glucagon Drug Market Challenges
Table 22. Global Glucagon Drug Sales by Type (K MT)
Table 23. Global Glucagon Drug Market Size by Type (M USD)
Table 24. Global Glucagon Drug Sales (K MT) by Type (2019-2025)
Table 25. Global Glucagon Drug Sales Market Share by Type (2019-2025)
Table 26. Global Glucagon Drug Market Size (M USD) by Type (2019-2025)
Table 27. Global Glucagon Drug Market Size Share by Type (2019-2025)
Table 28. Global Glucagon Drug Price (USD/MT) by Type (2019-2025)
Table 29. Global Glucagon Drug Sales (K MT) by Application
Table 30. Global Glucagon Drug Market Size by Application
Table 31. Global Glucagon Drug Sales by Application (2019-2025) & (K MT)
Table 32. Global Glucagon Drug Sales Market Share by Application (2019-2025)
Table 33. Global Glucagon Drug Sales by Application (2019-2025) & (M USD)
Table 34. Global Glucagon Drug Market Share by Application (2019-2025)
Table 35. Global Glucagon Drug Sales Growth Rate by Application (2019-2025)
Table 36. Global Glucagon Drug Sales by Region (2019-2025) & (K MT)
Table 37. Global Glucagon Drug Sales Market Share by Region (2019-2025)
Table 38. North America Glucagon Drug Sales by Country (2019-2025) & (K MT)
Table 39. Europe Glucagon Drug Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Glucagon Drug Sales by Region (2019-2025) & (K MT)
Table 41. South America Glucagon Drug Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Glucagon Drug Sales by Region (2019-2025) & (K MT)
Table 43. Global Glucagon Drug Production (K MT) by Region (2019-2025)
Table 44. Global Glucagon Drug Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Glucagon Drug Revenue Market Share by Region (2019-2025)
Table 46. Global Glucagon Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Glucagon Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Glucagon Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Glucagon Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Glucagon Drug Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Novo Nordisk Glucagon Drug Basic Information
Table 52. Novo Nordisk Glucagon Drug Product Overview
Table 53. Novo Nordisk Glucagon Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Novo Nordisk Business Overview
Table 55. Novo Nordisk Glucagon Drug SWOT Analysis
Table 56. Novo Nordisk Recent Developments
Table 57. Eli Lilly Glucagon Drug Basic Information
Table 58. Eli Lilly Glucagon Drug Product Overview
Table 59. Eli Lilly Glucagon Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. Eli Lilly Business Overview
Table 61. Eli Lilly Glucagon Drug SWOT Analysis
Table 62. Eli Lilly Recent Developments
Table 63. Fresenius Kabi Glucagon Drug Basic Information
Table 64. Fresenius Kabi Glucagon Drug Product Overview
Table 65. Fresenius Kabi Glucagon Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Fresenius Kabi Glucagon Drug SWOT Analysis
Table 67. Fresenius Kabi Business Overview
Table 68. Fresenius Kabi Recent Developments
Table 69. Torrent Labs Glucagon Drug Basic Information
Table 70. Torrent Labs Glucagon Drug Product Overview
Table 71. Torrent Labs Glucagon Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Torrent Labs Business Overview
Table 73. Torrent Labs Recent Developments
Table 74. Amphastar Pharmaceuticals Glucagon Drug Basic Information
Table 75. Amphastar Pharmaceuticals Glucagon Drug Product Overview
Table 76. Amphastar Pharmaceuticals Glucagon Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Amphastar Pharmaceuticals Business Overview
Table 78. Amphastar Pharmaceuticals Recent Developments
Table 79. Xeris Pharmaceuticals Glucagon Drug Basic Information
Table 80. Xeris Pharmaceuticals Glucagon Drug Product Overview
Table 81. Xeris Pharmaceuticals Glucagon Drug Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. Xeris Pharmaceuticals Business Overview
Table 83. Xeris Pharmaceuticals Recent Developments
Table 84. Global Glucagon Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 85. Global Glucagon Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 86. North America Glucagon Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 87. North America Glucagon Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 88. Europe Glucagon Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 89. Europe Glucagon Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 90. Asia Pacific Glucagon Drug Sales Forecast by Region (2025-2032) & (K MT)
Table 91. Asia Pacific Glucagon Drug Market Size Forecast by Region (2025-2032) & (M USD)
Table 92. South America Glucagon Drug Sales Forecast by Country (2025-2032) & (K MT)
Table 93. South America Glucagon Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 94. Middle East and Africa Glucagon Drug Consumption Forecast by Country (2025-2032) & (Units)
Table 95. Middle East and Africa Glucagon Drug Market Size Forecast by Country (2025-2032) & (M USD)
Table 96. Global Glucagon Drug Sales Forecast by Type (2025-2032) & (K MT)
Table 97. Global Glucagon Drug Market Size Forecast by Type (2025-2032) & (M USD)
Table 98. Global Glucagon Drug Price Forecast by Type (2025-2032) & (USD/MT)
Table 99. Global Glucagon Drug Sales (K MT) Forecast by Application (2025-2032)
Table 100. Global Glucagon Drug Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Glucagon Drug
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Glucagon Drug Market Size (M USD), 2019-2032
Figure 5. Global Glucagon Drug Market Size (M USD) (2019-2032)
Figure 6. Global Glucagon Drug Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Glucagon Drug Market Size by Country (M USD)
Figure 11. Glucagon Drug Sales Share by Manufacturers in 2023
Figure 12. Global Glucagon Drug Revenue Share by Manufacturers in 2023
Figure 13. Glucagon Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Glucagon Drug Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Glucagon Drug Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Glucagon Drug Market Share by Type
Figure 18. Sales Market Share of Glucagon Drug by Type (2019-2025)
Figure 19. Sales Market Share of Glucagon Drug by Type in 2023
Figure 20. Market Size Share of Glucagon Drug by Type (2019-2025)
Figure 21. Market Size Market Share of Glucagon Drug by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Glucagon Drug Market Share by Application
Figure 24. Global Glucagon Drug Sales Market Share by Application (2019-2025)
Figure 25. Global Glucagon Drug Sales Market Share by Application in 2023
Figure 26. Global Glucagon Drug Market Share by Application (2019-2025)
Figure 27. Global Glucagon Drug Market Share by Application in 2023
Figure 28. Global Glucagon Drug Sales Growth Rate by Application (2019-2025)
Figure 29. Global Glucagon Drug Sales Market Share by Region (2019-2025)
Figure 30. North America Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Glucagon Drug Sales Market Share by Country in 2023
Figure 32. U.S. Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Glucagon Drug Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Glucagon Drug Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Glucagon Drug Sales Market Share by Country in 2023
Figure 37. Germany Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Glucagon Drug Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Glucagon Drug Sales Market Share by Region in 2023
Figure 44. China Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Glucagon Drug Sales and Growth Rate (K MT)
Figure 50. South America Glucagon Drug Sales Market Share by Country in 2023
Figure 51. Brazil Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Glucagon Drug Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Glucagon Drug Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Glucagon Drug Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Glucagon Drug Production Market Share by Region (2019-2025)
Figure 62. North America Glucagon Drug Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Glucagon Drug Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Glucagon Drug Production (K MT) Growth Rate (2019-2025)
Figure 65. China Glucagon Drug Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Glucagon Drug Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Glucagon Drug Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Glucagon Drug Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Glucagon Drug Market Share Forecast by Type (2025-2032)
Figure 70. Global Glucagon Drug Sales Forecast by Application (2025-2032)
Figure 71. Global Glucagon Drug Market Share Forecast by Application (2025-2032)
